NVO vs. MITSY
NVO (Novo Nordisk A/S) and MITSY (Mitsui & Company Ltd) are both stocks. NVO operates in Drug Manufacturers - General (Healthcare), while MITSY operates in Conglomerates (Industrials). Over the past 10 years, NVO returned 7.56%/yr vs 18.81%/yr for MITSY. At a 0.18 correlation, their price movements are largely independent.
Performance
NVO vs. MITSY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVO achieves a -10.74% return, which is significantly lower than MITSY's 3.00% return. Over the past 10 years, NVO has underperformed MITSY with an annualized return of 7.56%, while MITSY has yielded a comparatively higher 18.81% annualized return.
NVO
- 1D
- -0.18%
- 1M
- -1.92%
- YTD
- -10.74%
- 6M
- -9.50%
- 1Y
- -42.47%
- 3Y*
- -15.59%
- 5Y*
- 2.92%
- 10Y*
- 7.56%
MITSY
- 1D
- -2.40%
- 1M
- -22.13%
- YTD
- 3.00%
- 6M
- 3.13%
- 1Y
- 48.76%
- 3Y*
- 18.70%
- 5Y*
- 21.77%
- 10Y*
- 18.81%
NVO vs. MITSY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | -10.74% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
MITSY Mitsui & Company Ltd | 3.00% | 43.31% | 13.10% | 28.00% | 23.12% | 28.70% | 4.06% | 14.13% | -4.90% | 20.93% |
Correlation
The correlation between NVO and MITSY is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Apr 25, 2011 | 0.18 |
Fundamentals
NVO:
$195.21B
MITSY:
$86.00B
NVO:
DKK 27.42
MITSY:
¥5.90K
NVO:
10.34
MITSY:
16.41
NVO:
0.44
MITSY:
4.74
NVO:
3.85
MITSY:
0.98
NVO:
6.21
MITSY:
1.56
NVO:
DKK 327.80B
MITSY:
¥14.19T
NVO:
DKK 268.30B
MITSY:
¥1.35T
NVO:
DKK 181.54B
MITSY:
¥1.01T
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVO vs. MITSY — Risk / Return Rank
NVO
MITSY
NVO vs. MITSY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and Mitsui & Company Ltd (MITSY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVO | MITSY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.38 | ||
| Sortino ratioReturn per unit of downside risk | -3.22 | ||
| Omega ratioGain probability vs. loss probability | 0.85 | 1.26 | -0.41 |
| Calmar ratioReturn relative to maximum drawdown | -0.80 | 1.79 | -2.59 |
| Martin ratioReturn relative to average drawdown | -1.18 | 7.05 | -8.23 |
Loading charts...
Drawdowns
NVO vs. MITSY - Drawdown Comparison
The maximum NVO drawdown since its inception was -74.70%, which is greater than MITSY's maximum drawdown of -44.45%. Use the drawdown chart below to compare losses from any high point for NVO and MITSY.
Loading charts...
Drawdown Indicators
| NVO | MITSY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.70% | -44.45% | -30.25% |
Max Drawdown (1Y)Largest decline over 1 year | -54.34% | -26.50% | -27.84% |
Max Drawdown (3Y)Largest decline over 3 years | -74.70% | -33.95% | -40.75% |
Max Drawdown (5Y)Largest decline over 5 years | -74.70% | -33.95% | -40.75% |
Max Drawdown (10Y)Largest decline over 10 years | -74.70% | -33.95% | -40.75% |
Current DrawdownCurrent decline from peak | -68.11% | -25.90% | -42.21% |
Average DrawdownAverage peak-to-trough decline | -17.79% | -16.07% | -1.72% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.62% | 6.71% | +30.91% |
Volatility
NVO vs. MITSY - Volatility Comparison
Novo Nordisk A/S (NVO) has a higher volatility of 10.68% compared to Mitsui & Company Ltd (MITSY) at 9.77%. This indicates that NVO's price experiences larger fluctuations and is considered to be riskier than MITSY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVO | MITSY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.68% | 9.77% | +0.91% |
Volatility (6M)Calculated over the trailing 6-month period | 38.04% | 24.95% | +13.09% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.88% | 30.84% | +21.04% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.33% | 29.74% | +8.59% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.56% | 26.76% | +5.80% |
Dividends
NVO vs. MITSY - Dividend Comparison
NVO's dividend yield for the trailing twelve months is around 4.11%, while MITSY has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MITSY Mitsui & Company Ltd | 0.00% | 1.17% | 1.61% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.65% | 3.82% | 0.00% |
NVO Novo Nordisk A/S | 4.11% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
NVO vs. MITSY - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and Mitsui & Company Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NVO vs. MITSY - Profitability Comparison
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
MITSY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Mitsui & Company Ltd reported a gross profit of 368.30B and revenue of 3.71T. Therefore, the gross margin over that period was 9.9%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
MITSY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Mitsui & Company Ltd reported an operating income of 106.13B and revenue of 3.71T, resulting in an operating margin of 2.9%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
MITSY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Mitsui & Company Ltd reported a net income of 226.10B and revenue of 3.71T, resulting in a net margin of 6.1%.
Frequently Asked Questions
NVO and MITSY have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVO has higher volatility (10.68%) compared to MITSY (9.77%). In terms of maximum drawdown, NVO dropped -74.70% vs MITSY's -44.45%.
MITSY currently has the higher Sharpe Ratio (1.54 vs -0.84), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVO and MITSY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer